Marken Announces Depot in Russia; Makes Senior Appointment - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Marken Announces Depot in Russia; Makes Senior Appointment



Marken, a provider of clinical-trial material supply solutions, has added a depot in Moscow as part of its global pharmaceutical depot network. The Russian depot will be located within an existing GxP-compliant storage facility in Moscow. The facility will be operated by staff trained on Marken’s global procedures and managed by the inventory system, Solo. It joins Marken’s current network of depots in China, Singapore, Argentina, Mexico, Germany, and the United States.

Marken’s network of pharmaceutical depot facilities and supporting IT systems are designed to provide storage and distribution of materials for clinical trials. They are designed for all clinical materials, including temperature-controlled and time-sensitive products.

In other news, Marken has appointed Michael Culme-Seymour as vice-president, Asia Pacific Region, effective Oct. 14, 2013. Culme-Seymour will be responsible for clinical logistics and Marken’s seven branches in the region, including: Singapore, Australia, India, China, Japan, Hong Kong, and Korea. Culme-Seymour has 22 years of logistics experience with airlines, express couriers, and major post companies in Singapore, Zurich, and London.  He was most recently owner of Fischer Road Express, a private company specializing in life-science logistics. 

Source: Marken

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
28%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here